The present observational study was based on data from a multicenter registry regarding the clinical efficacy of abatacept, tocilizumab, and etanercept in patients with RA in whom anti-TNF monoclonal antibody therapy previously failed. The gene discussed is TNF; the disease is rheumatoid arthritis.